Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
ALX Oncology Holdings Inc. (ALXO) had Return on Tangible Equity of -391.42% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-101.69M |
|
-- |
|
-- |
|
$104.02M |
|
$-104.02M |
|
$2.33M |
|
$-101.69M |
|
$-101.69M |
|
$-101.69M |
|
$-101.69M |
|
$-101.69M |
|
$-101.69M |
|
$-104.02M |
|
$-104.28M |
|
53.66M |
|
53.66M |
|
$-1.90 |
|
$-1.90 |
|
| Balance Sheet Financials | |
$50.73M |
|
$1.20M |
|
$8.32M |
|
$59.05M |
|
$24.55M |
|
$4.53M |
|
$8.51M |
|
$33.06M |
|
$25.98M |
|
$25.98M |
|
$25.98M |
|
54.39M |
|
| Cash Flow Statement Financials | |
$-84.14M |
|
$82.59M |
|
$0.36M |
|
$17.63M |
|
$16.44M |
|
$-1.19M |
|
$12.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.07 |
|
-- |
|
-- |
|
0.15 |
|
0.38 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-84.35M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-391.42% |
|
|
Return on Tangible Equity |
-391.42% |
-172.23% |
|
-333.28% |
|
$0.48 |
|
$-1.57 |
|
$-1.57 |
|